A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
Condition(s):HyperkalemiaLast Updated:October 28, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):HyperkalemiaLast Updated:October 28, 2022Recruiting
Condition(s):TumorsLast Updated:April 11, 2011Completed
Condition(s):Cognition Disorders in Old Age; Mild Cognitive Impairment; Cognitive DeclineLast Updated:December 21, 2022Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:September 22, 2016Completed
Condition(s):Coronary Artery DiseaseLast Updated:July 6, 2023Not yet recruiting
Condition(s):Coronary Artery DiseaseLast Updated:January 30, 2023Not yet recruiting
Condition(s):Breast CancerLast Updated:June 13, 2023Not yet recruiting
Condition(s):Functional Abdominal PainLast Updated:August 30, 2017Terminated
Condition(s):HIV InfectionsLast Updated:February 6, 2024Active, not recruiting
Condition(s):Healthy, MaleLast Updated:July 6, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.